cyclohexanol has been researched along with Panic Disorder in 26 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 7 (26.92) | 18.2507 |
| 2000's | 16 (61.54) | 29.6817 |
| 2010's | 3 (11.54) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Akbudak, M; Belli, H; Tabo, A; Ural, C | 1 |
| Asnis, G; Liebowitz, MR; Mangano, R; Tzanis, E | 1 |
| Boerner, RJ | 1 |
| Orenstein, H; Raskind, MA | 1 |
| Cassano, GB; Mula, M; Pini, S; Preve, M | 1 |
| Ninan, PT | 2 |
| Bellodi, L; Bertani, A; Bussi, R; Caldirola, D; Cucchi, M; Perna, G | 1 |
| Silk, KR; Yager, J | 1 |
| Bharucha, A; Lenze, EJ; Mulsant, BH; Pollock, BG; Reynolds, CF; Shear, MK | 1 |
| Andrews, G; Carter, R; Donnelly, M; Haby, MM; Heuzenroeder, L; Mihalopoulos, C; Rossell, R; Vos, T | 1 |
| Hsiao, MC; Lin, YH; Liu, CY | 1 |
| Ahokas, A; Bradwejn, J; Emilien, G; Salinas, E; Stein, DJ; Whitaker, T | 1 |
| Papadimitriou, GN; Psarros, C; Sakkas, P; Soldatos, CR; Theleritis, CG | 1 |
| Emilien, G; Gao, B; Koponen, H; Lepola, U; Pollack, MH; Salinas, E; Simon, NM; Tzanis, E; Whitaker, T; Worthington, JJ | 1 |
| Entsuah, R; Ferguson, JM; Khan, A; Mangano, R; Tzanis, E | 1 |
| Chang, YY; Chong, MY; Lee, Y; Lin, PY; Yeh, WC | 1 |
| Entsuah, R; Mangano, R; Pollack, M; Simon, NM; Tzanis, E; Zhang, Y | 1 |
| Coupland, NJ | 1 |
| Geracioti, TD | 1 |
| Maki, KM; Manfro, GG; Otto, MW; Pollack, MH; Rosenbaum, JF; Rudolph, R; Smoller, JW; Worthington, JJ | 1 |
| Benazzi, F | 1 |
| Gorman, JM | 1 |
| Bhatara, VS; Magnus, RD; Paul, KL; Preskorn, SH | 1 |
| Amchin, J; Coplan, JD; Gorman, JM; Martinez, JM; Papp, LA; Sinha, SS | 1 |
| Busch, FN; Gabbard, GO; Milrod, BL | 1 |
5 review(s) available for cyclohexanol and Panic Disorder
| Article | Year |
|---|---|
[Anxiety disorders: diagnosis and therapy from the family physician's perspective].
Topics: Antidepressive Agents; Antidepressive Agents, Second-Generation; Anxiety Disorders; Behavior Therapy; Cognitive Behavioral Therapy; Cyclohexanols; Diagnosis, Differential; Family Practice; Humans; Panic Disorder; Paroxetine; Practice Guidelines as Topic; Selective Serotonin Reuptake Inhibitors; Venlafaxine Hydrochloride | 2006 |
Treatment considerations for anxiety in the elderly.
Topics: Aged; Anxiety Disorders; Cognition Disorders; Cyclohexanols; Diagnosis, Differential; Humans; Panic Disorder; Selective Serotonin Reuptake Inhibitors; Stress Disorders, Post-Traumatic; Venlafaxine Hydrochloride | 2003 |
Cost-effectiveness of psychological and pharmacological interventions for generalized anxiety disorder and panic disorder.
Topics: Antidepressive Agents, Tricyclic; Anxiety Disorders; Australia; Cost-Benefit Analysis; Cyclohexanols; Disability Evaluation; Humans; Imipramine; Mental Health Services; Panic Disorder; Paroxetine; Psychotherapy; Selective Serotonin Reuptake Inhibitors; Time Factors; Venlafaxine Hydrochloride | 2004 |
The use of newer antidepressants for panic disorder.
Topics: 1-Naphthylamine; Antidepressive Agents, Second-Generation; Antidepressive Agents, Tricyclic; Benzodiazepines; Clinical Trials as Topic; Cognitive Behavioral Therapy; Combined Modality Therapy; Cyclohexanols; Fluoxetine; Fluvoxamine; Humans; Monoamine Oxidase Inhibitors; Panic Disorder; Paroxetine; Selective Serotonin Reuptake Inhibitors; Sertraline; Treatment Outcome; Venlafaxine Hydrochloride | 1997 |
Use of venlafaxine in other psychiatric disorders.
Topics: Anxiety; Attention Deficit Disorder with Hyperactivity; Clinical Trials as Topic; Cyclohexanols; Depressive Disorder, Major; Fibromyalgia; Humans; Obsessive-Compulsive Disorder; Panic Disorder; Phobic Disorders; Selective Serotonin Reuptake Inhibitors; Trichotillomania; Venlafaxine Hydrochloride | 2000 |
9 trial(s) available for cyclohexanol and Panic Disorder
| Article | Year |
|---|---|
Open-longitudinal study of the effect of dissociative symptoms on the response of patients with panic disorder to venlafaxine.
Topics: Adolescent; Adult; Antidepressive Agents, Second-Generation; Cyclohexanols; Dissociative Disorders; Dose-Response Relationship, Drug; Female; Humans; Longitudinal Studies; Male; Middle Aged; Panic Disorder; Psychiatric Status Rating Scales; Socioeconomic Factors; Treatment Outcome; Venlafaxine Hydrochloride; Young Adult | 2015 |
A double-blind, placebo-controlled, parallel-group, flexible-dose study of venlafaxine extended release capsules in adult outpatients with panic disorder.
Topics: Ambulatory Care; Cyclohexanols; Delayed-Action Preparations; Double-Blind Method; Drug Administration Schedule; Humans; Panic Disorder; Selective Serotonin Reuptake Inhibitors; Severity of Illness Index; Surveys and Questionnaires; Venlafaxine Hydrochloride | 2009 |
Venlafaxine extended-release capsules in panic disorder: flexible-dose, double-blind, placebo-controlled study.
Topics: Adult; Analysis of Variance; Anxiety; Capsules; Cholesterol; Cyclohexanols; Delayed-Action Preparations; Double-Blind Method; Drug Administration Schedule; Electrocardiography; Fear; Female; Heart Rate; Humans; Male; Panic Disorder; Patient Compliance; Selective Serotonin Reuptake Inhibitors; Treatment Outcome; Venlafaxine Hydrochloride | 2005 |
A double-blind study of the efficacy of venlafaxine extended-release, paroxetine, and placebo in the treatment of panic disorder.
Topics: Adult; Agoraphobia; Antidepressive Agents, Second-Generation; Cyclohexanols; Delayed-Action Preparations; Dose-Response Relationship, Drug; Double-Blind Method; Female; Humans; Male; Middle Aged; Panic Disorder; Paroxetine; Personality Inventory; Psychometrics; Quality of Life; Treatment Outcome; Venlafaxine Hydrochloride | 2007 |
Relapse prevention of panic disorder in adult outpatient responders to treatment with venlafaxine extended release.
Topics: Adult; Cyclohexanols; Delayed-Action Preparations; Disabled Persons; Double-Blind Method; Female; Humans; Kaplan-Meier Estimate; Male; Middle Aged; Outpatients; Panic Disorder; Quality of Life; Secondary Prevention; Selective Serotonin Reuptake Inhibitors; Treatment Outcome; Venlafaxine Hydrochloride | 2007 |
A randomized controlled trial of venlafaxine ER and paroxetine in the treatment of outpatients with panic disorder.
Topics: Abortion, Spontaneous; Administration, Oral; Adult; Affective Disorders, Psychotic; Cyclohexanols; Delayed-Action Preparations; Diagnostic and Statistical Manual of Mental Disorders; Diarrhea; Dose-Response Relationship, Drug; Double-Blind Method; Female; Humans; Male; Middle Aged; Outpatients; Panic Disorder; Paroxetine; Pregnancy; Pregnancy, Unplanned; Remission Induction; Selective Serotonin Reuptake Inhibitors; Time Factors; Treatment Outcome; Venlafaxine Hydrochloride | 2007 |
Venlafaxine treatment of panic disorder: a case series.
Topics: Adult; Cyclohexanols; Dose-Response Relationship, Drug; Drug Administration Schedule; Female; Humans; Male; Middle Aged; Panic Disorder; Selective Serotonin Reuptake Inhibitors; Treatment Outcome; Venlafaxine Hydrochloride | 1995 |
Venlafaxine for panic disorder: results from a double-blind, placebo-controlled study.
Topics: Adult; Antidepressive Agents, Second-Generation; Cyclohexanols; Double-Blind Method; Female; Humans; Male; Middle Aged; Panic Disorder; Venlafaxine Hydrochloride | 1996 |
Low-dose venlafaxine treatment in panic disorder.
Topics: Adult; Antidepressive Agents, Second-Generation; Cyclohexanols; Dose-Response Relationship, Drug; Female; Humans; Male; Panic Disorder; Psychiatric Status Rating Scales; Venlafaxine Hydrochloride | 1998 |
12 other study(ies) available for cyclohexanol and Panic Disorder
| Article | Year |
|---|---|
Dosing by side effect threshold: two cases of panic disorder responsive to low-dose venlafaxine.
Topics: Adult; Cyclohexanols; Female; Humans; Middle Aged; Panic Disorder; Selective Serotonin Reuptake Inhibitors; Venlafaxine Hydrochloride | 2010 |
Venlafaxine in somatopsychic and autopsychic depersonalization.
Topics: Agoraphobia; Cyclohexanols; Depersonalization; Depressive Disorder; Humans; Male; Obsessive Behavior; Panic Disorder; Paroxetine; Retreatment; Selective Serotonin Reuptake Inhibitors; Trimipramine; Venlafaxine Hydrochloride; Young Adult | 2011 |
Pharmacokinetically induced benzodiazepine withdrawal.
Topics: Alprazolam; Anti-Anxiety Agents; Antidepressive Agents, Second-Generation; Cyclohexanols; Drug Interactions; Female; Humans; Middle Aged; Panic Disorder; Piperazines; Substance Withdrawal Syndrome; Triazoles; Venlafaxine Hydrochloride | 2001 |
The effect of one-week treatment with venlafaxine on 35% CO2 hyperreactivity in patients with panic disorder: an open study.
Topics: Antidepressive Agents, Second-Generation; Carbon Dioxide; Cyclohexanols; Humans; Panic Disorder; Psychiatric Status Rating Scales; Venlafaxine Hydrochloride | 2003 |
Suggested guidelines for e-mail communication in psychiatric practice.
Topics: Adult; Borderline Personality Disorder; Combined Modality Therapy; Cyclohexanols; Electronic Mail; Female; Guidelines as Topic; Humans; Panic Disorder; Physician-Patient Relations; Practice Patterns, Physicians'; Privacy; Psychiatry; Psychotherapy; Selective Serotonin Reuptake Inhibitors; Venlafaxine Hydrochloride | 2003 |
Combined antidepressant and hormone treatment is effective for chemotherapy-induced menopausal syndrome.
Topics: Adult; Antidepressive Agents, Second-Generation; Combined Modality Therapy; Contraceptives, Oral, Synthetic; Cyclohexanols; Depressive Disorder; Drug-Related Side Effects and Adverse Reactions; Estrogens; Female; Follicle Stimulating Hormone; Humans; Lymphoma, B-Cell; Medroxyprogesterone; Menopause, Premature; Panic Disorder; Psychiatric Status Rating Scales; Severity of Illness Index; Venlafaxine Hydrochloride | 2005 |
Repetitive transcranial magnetic stimulation (rTMS) in a patient suffering from comorbid depression and panic disorder following a myocardial infarction.
Topics: Anti-Anxiety Agents; Antidepressive Agents, Second-Generation; Citalopram; Clorazepate Dipotassium; Cyclohexanols; Depressive Disorder; Humans; Male; Middle Aged; Myocardial Infarction; Panic Disorder; Psychiatric Status Rating Scales; Transcranial Magnetic Stimulation; Venlafaxine Hydrochloride | 2006 |
Venlafaxine and tardive blepharospasm: a case report.
Topics: Adult; Antidepressive Agents, Second-Generation; Blepharospasm; Cyclohexanols; Dyskinesia, Drug-Induced; Humans; Male; Panic Disorder; Venlafaxine Hydrochloride | 2007 |
Combined antidepressants and CBT for panic disorder with agoraphobia.
Topics: Adult; Agoraphobia; Antidepressive Agents; Cognitive Behavioral Therapy; Combined Modality Therapy; Cyclohexanols; Female; Humans; Panic Disorder; Venlafaxine Hydrochloride | 2008 |
Dangerous interaction with nefazodone added to fluoxetine, desipramine, venlafaxine, valproate and clonazepam combination therapy.
Topics: Adult; Antidepressive Agents; Clonazepam; Cyclohexanols; Depressive Disorder; Desipramine; Drug Therapy, Combination; Female; Fluoxetine; Humans; Hypotension; Panic Disorder; Piperazines; Substance Withdrawal Syndrome; Triazoles; Venlafaxine Hydrochloride | 1997 |
Serotonin syndrome induced by venlafaxine and fluoxetine: a case study in polypharmacy and potential pharmacodynamic and pharmacokinetic mechanisms.
Topics: Adult; Cyclohexanols; Depressive Disorder; Drug Interactions; Female; Fluoxetine; Humans; Panic Disorder; Selective Serotonin Reuptake Inhibitors; Serotonin; Venlafaxine Hydrochloride | 1998 |
Comments on the APA Panic Disorder Guideline. American Psychiatric Association.
Topics: Caregivers; Cognitive Behavioral Therapy; Cyclohexanols; Follow-Up Studies; Humans; Panic Disorder; Practice Guidelines as Topic; Treatment Outcome; Venlafaxine Hydrochloride | 1998 |